THERESE BIRKAM-JADE: Open Payments
NPI 1124112982 · PORTAGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 50 payments from 13 companies in 2025. Trend: 2023 $1,033 · 2024 $700 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $156 |
| Lilly USA, LLC | 5 | $107 |
| Organon LLC | 12 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| LEO Pharma Inc. | 5 | $98 |
| Janssen Biotech, Inc. | 3 | $86 |
| GENZYME CORPORATION | 3 | $81 |
| UCB, Inc. | 2 | $51 |
| Amgen Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
Products named: DUPIXENT, SKYRIZI, VTAMA, ADBRY, EBGLYSS, TREMFYA, Bimzelx, OTEZLA.
Industry payments across MI — which companies pay providers there.
